AI drug development’s data problem
Edward Richard Gold, Robert Mullan Cook-Deegan · Science · 2025
The future of drug discovery may be artificial intelligence (AI), but its present is not. AI is in its infancy in the field. To help AI mature, developers need nonproprietary, open, large, high-quality datasets to train and validate models, managed by independent organizations.